SEARCH

SEARCH BY CITATION

REFERENCES

  • Adzhubei I, Jordan DM, Sunyaev SR. 2013. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet Chapter 7:Unit7.20.
  • Alliey-Rodriguez N, Zhang D, Badner JA, Lahey BB, Zhang X, Dinwiddie S, Romanos B, Plenys N, Liu C, Gershon ES. 2011. Genome-wide association study of personality traits in bipolar patients. Psychiatr Genet 21(4):190194.
  • Barrett JC. 2009. Haploview: Visualization and analysis of SNP genotype data. Cold Spring Harb Protoc 2009(10):pdb ip71.
  • Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263265.
  • Breen G, Lewis CM, Vassos E, Pergadia ML, Blackwood DH, Boomsma DI, Penninx B, Sullivan PF, Pedroso I, Collier D, et al. 2011. Replication of association of 3p21.1 with susceptibility to bipolar disorder but not major depression. Nat Genet 43(1):35 ; author reply 5.
  • Chatterjee S, Pal JK. 2009. Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biol Cell 101(5):251262.
  • Chen JM, Ferec C, Cooper DN. 2006. A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes II: The importance of mRNA secondary structure in assessing the functionality of 3′ UTR variants. Hum Genet 120(3):301333.
  • Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, Sleiman PM, Zhang H, Kim CE, Robison R, et al. 2012. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet 44(1):7884.
  • Etain B, Mathieu F, Rietschel M, Maier W, Albus M, McKeon P, Roche S, Kealey C, Blackwood D, Muir W, et al. 2006. Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: Supportive evidence for linkage at 3p14. Mol Psychiatry 11(7):685694.
  • Fabbri C, Drago A, Serretti A. 2013. Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR*D. Eur Neuropsychopharmacol 23(7):612621.
  • Fairbrother WG, Yeo GW, Yeh R, Goldstein P, Mawson M, Sharp PA, Burge CB. 2004. RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons. Nucleic Acids Res 32 (Web Server issue): W187W190.
  • Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, et al. 2005. Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77(6):918936.
  • Faraone SV, Biederman J, Wozniak J. 2012. Examining the comorbidity between attention deficit hyperactivity disorder and bipolar I disorder: A meta-analysis of family genetic studies. Am J Psychiatry 169(12):12561266.
  • Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, et al. 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40(9):10561058.
  • Filipowicz W, Bhattacharyya SN, Sonenberg N. 2008. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 9(2):102114.
  • Grillo G, Turi A, Licciulli F, Mignone F, Liuni S, Banfi S, Gennarino VA, Horner DS, Pavesi G, Picardi E, et al. 2010. UTRdb and UTRsite (RELEASE 2010): A collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs. Nucleic Acids Res 38 (Database issue): D75D80.
  • Grozeva D, Kirov G, Ivanov D, Jones IR, Jones L, Green EK, St Clair DM, Young AH, Ferrier N, Farmer AE, et al. 2010. Rare copy number variants: A point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry 67(4):318327.
  • Gu Z, Liu W, Wei J, Yan Z. 2012. Regulation of N-methyl-d-aspartic acid (NMDA) receptors by metabotropic glutamate receptor 7. J Biol Chem 287(13):1026510275.
  • Kandaswamy R, McQuillin A, Sharp SI, Fiorentino A, Anjorin A, Blizard RA, Curtis D, Gurling HM. 2013. Genetic association, mutation screening, and functional analysis of a Kozak sequence variant in the metabotropic glutamate receptor 3 gene in bipolar disorder. JAMA Psychiatry 70(6):591598.
  • Kelsoe JR, Spence MA, Loetscher E, Foguet M, Sadovnick AD, Remick RA, Flodman P, Khristich J, Mroczkowski-Parker Z, Brown JL, et al. 2001. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci USA 98(2):585590.
  • Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402408.
  • McGuffin P, Farmer A, Harvey I. 1991. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 48(8):764770.
  • McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. 2003. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 60(5):497502.
  • McQuillin A, Bass N, Anjorin A, Lawrence J, Kandaswamy R, Lydall G, Moran J, Sklar P, Purcell S, Gurling H. 2011. Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample. Eur J Hum Genet 19(5):588592.
  • Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, Kong XQ, Antoniades A, Domenici E, Perry J, Rothen S, et al. 2010. Genome-wide association study of recurrent major depressive disorder in two European case–control cohorts. Mol Psychiatry 15(6):589601.
  • Neale BM, Rivas MA, Voight BF, Altshuler D, Devlin B, Orho-Melander M, Kathiresan S, Purcell SM, Roeder K, Daly MJ. 2011. Testing for an unusual distribution of rare variants. PLoS Genet 7(3):e1001322.
  • O'Connor RM, Finger BC, Flor PJ, Cryan JF. 2010. Metabotropic glutamate receptor 7: At the interface of cognition and emotion. Eur J Pharmacol 639(1–3):123131.
  • Palucha A. 2006. Are compounds acting at metabotropic glutamate receptors the answer to treating depression? Expert Opin Investig Drugs 15(12):15451553.
  • Park S, Jung SW, Kim BN, Cho SC, Shin MS, Kim JW, Yoo HJ, Cho DY, Chung US, Son JW, et al. 2013. Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample. Behav Brain Funct 9:1.
  • Pereira AC, McQuillin A, Puri V, Anjorin A, Bass N, Kandaswamy R, Lawrence J, Curtis D, Sklar P, Purcell SM, et al. 2011. Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder. Am J Med Genet Part B 156B(2):177187.
  • Pergadia ML, Glowinski AL, Wray NR, Agrawal A, Saccone SF, Loukola A, Broms U, Korhonen T, Penninx BW, Grant JD, et al. 2011. A 3p26–3p25 genetic linkage finding for DSM-IV major depression in heavy smoking families. Am J Psychiatry 168(8):848852.
  • Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559575.
  • Sanderson TM, Collingridge GL, Fitzjohn SM. 2011. Differential trafficking of AMPA receptors following activation of NMDA receptors and mGluRs. Mol Brain 4:30.
  • Saus E, Brunet A, Armengol L, Alonso P, Crespo JM, Fernandez-Aranda F, Guitart M, Martin-Santos R, Menchon JM, Navines R, et al. 2010. Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. J Psychiatr Res 44(14):971978.
  • Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA, Lawson WB, DePaulo JR Jr, Gejman PV, Sanders AR, et al. 2011. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 16(2):193201.
  • Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, Flor PJ, Neki A, Abe T, Nakanishi S, et al. 1997. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci 17(19):75037522.
  • Shyn SI, Shi J, Kraft JB, Potash JB, Knowles JA, Weissman MM, Garriock HA, Yokoyama JS, McGrath PJ, Peters EJ, et al. 2011. Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. Mol Psychiatry 16(2):202215.
  • Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, et al. 2008. Whole-genome association study of bipolar disorder. Mol Psychiatry 13(6):558569.
  • Spitzer RL, Endicott J, Robins E. 1975. Research diagnostic criteria. Psychopharmacol Bull 11(3):2225.
  • Spitzer RL, Williams JB, Endicott J. 2012. Standards for DSM-5 reliability. Am J Psychiatry 169(5):537 ; author reply 537–538.
  • Staden R. 1996. The Staden sequence analysis package. Mol Biotechnol 5(3):233241.
  • Sullivan PF, de Geus EJ, Willemsen G, James MR, Smit JH, Zandbelt T, Arolt V, Baune BT, Blackwood D, Cichon S, et al. 2009. Genome-wide association for major depressive disorder: A possible role for the presynaptic protein piccolo. Mol Psychiatry 14(4):359375.
  • Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA, Schoepp DD. 2005. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov 4(2):131144.
  • Tang B, Thornton-Wells T, Askland KD. 2011. Comparative linkage meta-analysis reveals regionally-distinct, disparate genetic architectures: Application to bipolar disorder and schizophrenia. PLoS ONE 6(4):e19073.
  • Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, et al. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320(5875):539543.
  • WTCCC. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145):661678.
  • Zhang D, Cheng L, Qian Y, Alliey-Rodriguez N, Kelsoe JR, Greenwood T, Nievergelt C, Barrett TB, McKinney R, Schork N, et al. 2009. Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry 14(4):376380.
  • Zhou R, Yuan P, Wang Y, Hunsberger JG, Elkahloun A, Wei Y, Damschroder-Williams P, Du J, Chen G, Manji HK. 2009. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 34(6):13951405.